ArticleCommunications biology2026
Hierarchical organization of tau topography across the Alzheimer's disease continuum integrates amyloid, connectome, and intrinsic molecular vulnerability.
Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Tau pathology defines the Alzheimer's disease (AD) continuum and is spatially heterogeneous, yet the roles of amyloid-β (Aβ), connectome architecture, and intrinsic molecular vulnerability remain unclear. Here we integrated Aβ- and tau-PET, diffusion MRI, resting-state fMRI, and transcriptomic maps across the AD continuum. We found that tau pathology followed a hierarchical spatial gradient that progressively stratified by Aβ and clinical stages. Across the AD continuum, Aβ covariance and structural and functional connectivity were associated with tau covariance, and their derived propagation signatures further recapitulated regional tau burden, explaining substantial spatial variance. A residual tau pattern not captured by the modeled propagation signatures was further identified and was associated with reproducible transcriptional gradients involving intracellular signaling, synaptic programs, mitochondrial bioenergetics, and post-transcriptional regulation, with stage-specific shifts in biology. Importantly, tau geometry related to epicenter segregation and perivascular diffusion and mediated their associations with clinical expression. These findings position tau topography as an integrative marker coupling Aβ, connectivity, and intrinsic molecular vulnerability, and indicate that tau geometry is related to the link between network organization and cognitive decline.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.